SCI Pharmtech (Taiwan) Alpha and Beta Analysis

4119 Stock  TWD 97.50  0.50  0.51%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as SCI Pharmtech. It also helps investors analyze the systematic and unsystematic risks associated with investing in SCI Pharmtech over a specified time horizon. Remember, high SCI Pharmtech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to SCI Pharmtech's market risk premium analysis include:
Beta
0.0597
Alpha
0.12
Risk
0.72
Sharpe Ratio
0.2
Expected Return
0.15
Please note that although SCI Pharmtech alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, SCI Pharmtech did 0.12  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of SCI Pharmtech stock's relative risk over its benchmark. SCI Pharmtech has a beta of 0.06  . As returns on the market increase, SCI Pharmtech's returns are expected to increase less than the market. However, during the bear market, the loss of holding SCI Pharmtech is expected to be smaller as well. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out SCI Pharmtech Backtesting, SCI Pharmtech Valuation, SCI Pharmtech Correlation, SCI Pharmtech Hype Analysis, SCI Pharmtech Volatility, SCI Pharmtech History and analyze SCI Pharmtech Performance.

SCI Pharmtech Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. SCI Pharmtech market risk premium is the additional return an investor will receive from holding SCI Pharmtech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in SCI Pharmtech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate SCI Pharmtech's performance over market.
α0.12   β0.06

SCI Pharmtech expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of SCI Pharmtech's Buy-and-hold return. Our buy-and-hold chart shows how SCI Pharmtech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

SCI Pharmtech Market Price Analysis

Market price analysis indicators help investors to evaluate how SCI Pharmtech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading SCI Pharmtech shares will generate the highest return on investment. By understating and applying SCI Pharmtech stock market price indicators, traders can identify SCI Pharmtech position entry and exit signals to maximize returns.

SCI Pharmtech Return and Market Media

The median price of SCI Pharmtech for the period between Sun, Aug 25, 2024 and Sat, Nov 23, 2024 is 89.6 with a coefficient of variation of 3.07. The daily time series for the period is distributed with a sample standard deviation of 2.78, arithmetic mean of 90.28, and mean deviation of 2.01. The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About SCI Pharmtech Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including SCI or other stocks. Alpha measures the amount that position in SCI Pharmtech has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards SCI Pharmtech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, SCI Pharmtech's short interest history, or implied volatility extrapolated from SCI Pharmtech options trading.

Build Portfolio with SCI Pharmtech

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for SCI Stock Analysis

When running SCI Pharmtech's price analysis, check to measure SCI Pharmtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SCI Pharmtech is operating at the current time. Most of SCI Pharmtech's value examination focuses on studying past and present price action to predict the probability of SCI Pharmtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SCI Pharmtech's price. Additionally, you may evaluate how the addition of SCI Pharmtech to your portfolios can decrease your overall portfolio volatility.